Symptom scales | n | mean | SD |
---|---|---|---|
Painful sites | |||
baseline (t0) | 30 | 42.00 | 26.27 |
3 months (t2) | 24 | 36.67 | 24.48 |
Treatment effect (t0-t2) after 3 months p = 0.346 | |||
Effect size (t0-t2) after 3 months = 0.21 | |||
Pain characteristics | |||
baseline (t0) | 30 | 47.04 | 33.10 |
3 months (t2) | 24 | 39.35 | 34.67 |
Treatment effect (t0-t2) after 3 months p = 0.172 | |||
Effect size (t0-t2) after 3 months = 0.33 | |||
Functional interference | |||
baseline (t0) | 30 | 53.06 | 28.17 |
3 months (t2) | 24 | 46.18 | 28.55 |
Treatment effect (t0-t2) after 3 months p = 0.186 | |||
Effect size (t0-t2) after 3 months = 0.26 | |||
Psychosocial aspects | |||
baseline (t0) | 30 | 60.19 | 21.50 |
3 months (t2) | 24 | 56.48 | 21.2 |
Treatment effect (t0-t2) after 3 months p = 0.082 | |||
Effect size (t0-t2) after 3 months = 0.34 |